Home > Boards > US OTC > Medical - Healthcare > MMRGlobal, Inc. (MMRF)

The competition to Rituximab for Anti-CD20: Mentrik's

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Frankinjohn74 Member Profile Frankinjohn74  
Friday, July 20, 2012 11:07:44 PM
Re: None Post # of 59685 
The competition to Rituximab for Anti-CD20: Mentrik's Next-generation Anti-CD20 Monoclonal Antibody. Wonder how much they could benefit (accelerate) from MMR/former Favrille anti-CD20 bio data?
http://www.prlog.org/11789915-mentriks-next-generation-anti-cd20-monoclonal-antibody-ame-133v-receives-generic-name-oca.html




MMRGlobal, Inc. (MMRF) Stock Trading Info:
MMRGlobal, Inc. MMRF Stock Quote MMRGlobal, Inc. MMRF Stock Charts MMRGlobal, Inc. MMRF Financial
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist